Evidence map›Paper›PMID 29866385›Full record

Trial reportJournal of substance abuse treatment2018

Patient predictors of substance use disorder treatment initiation in primary care.

Allison J Ober, Katherine E Watkins, Colleen M McCullough, Claude M Setodji, Karen Osilla, Sarah B Hunter

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance abuse treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Medicaid health home design and buprenorphine receipt, 2009-2020.Journal of substance use and addiction treatment · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Allison J OberRAND Corporation, 1776 Main Street Santa Monica, CA 90407, USA. Electronic address: ober@rand.org.
Katherine E WatkinsRAND Corporation, 1776 Main Street Santa Monica, CA 90407, USA. Electronic address: kwatkins@rand.org.
Colleen M McCulloughRAND Corporation, 1776 Main Street Santa Monica, CA 90407, USA. Electronic address: cmccullo@rand.org.
Claude M SetodjiRAND Corporation, 1776 Main Street Santa Monica, CA 90407, USA. Electronic address: Setodji@rand.org.
Karen OsillaRAND Corporation, 1776 Main Street Santa Monica, CA 90407, USA. Electronic address: karenc@rand.org.
Sarah B HunterRAND Corporation, 1776 Main Street Santa Monica, CA 90407, USA. Electronic address: shunter@rand.org.
RAND Corporation · US

Funding

Integrated Collaborative Care for Substance Use DisordersR01DA034266 · NIDA · RAND CORPORATION · PI WATKINS, KATHERINE E · 2012 to 2016
$4.0M
NIDA NIH HHS R01 DA034266
6 · The paper itself

Abstract

introductionPrimary care clinics are opportune settings in which to deliver substance use disorder (SUD) treatment, but little is known about which patients initiate treatment in these settings.

methodsUsing secondary data from a RCT that aimed to integrate SUD treatment into a federally qualified health center (FQHC) using an organizational readiness and collaborative care (CC) intervention, we examined patient-level predictors of initiation of evidence-based practices for opioid and/or alcohol use disorders (OAUDs): a brief behavioral treatment (BT) based on motivational interviewing and cognitive behavioral therapy and medication-assisted treatment (MAT) (extended-release injectable naltrexone (XR-NTX) for patients with an alcohol use disorder or opioid use disorder and buprenorphine/naloxone (BUP/NX) for patients with an opioid use disorder). Using the Andersen model of health care access, we tested bivariate and multivariate logistic regression models to assess associations between patient factors and initiation of BT and MAT.

resultsTwenty-three percent of all participants (N = 392) received BT and 13% received MAT. In the multivariate model examining factors associated with initiation of BT, being of "other" or "multiple" races compared with being White (OR = 0.45, CI = 0.22, 0.92), being homeless (OR = 0.45, CI = 0.21, 0.97) and having been arrested within 90 days of baseline (OR = 0.21 CI = 0.63, 0.69) were associated with significantly lower odds of initiating BT. Greater self-stigma (OR = 1.60, CI = 1.06, 2.42), receiving MAT (OR = 5.52, CI = 2.34, 12.98), and having received the CC study intervention (OR = 12.95, CI = 5.91, 28.37) were associated with higher odds of initiating BT. In the multivariate model examining patient factors associated with initiating MAT, older age (OR = 1.07, CI = 1.03, 1.11), female gender (OR = 3.05, CI = 1.25, 7.46), having a diagnosis of heroin abuse or dependence (with or without alcohol abuse or dependence compared with have a diagnosis of alcohol dependence only (OR = 3.03, CI = 1.17, 7.86), and having received at least one session of BT (OR = 6.42, CI = 2.59, 15.94), were associated with higher odds of initiating MAT.

conclusionsIndividuals who initiate BT for OAUDs in a FQHC are less likely to be homeless and more likely to have greater self-stigma. Those who receive MAT are more likely to be of older age, female, and to have a diagnosis of heroin abuse or dependence, with or without concomitant alcohol abuse or dependence, rather than alcohol abuse or dependence alone. Receiving collaborative care (e.g., a warm handoff, and follow-up by a care coordinator) may be critical to initiating BT. Receiving at least one session of BT is associated with higher odds of receiving MAT, and receiving MAT is associated with higher odds of receiving BT. The Andersen model of health care access provides some insight into who initiates BT and MAT for OAUD treatment in FQHC-based primary care; further research is needed to explore system-level factors that may also influence treatment initiation.

Indexed as

AdultAge FactorsAlcoholismBuprenorphine, Naloxone Drug CombinationCognitive Behavioral TherapyCooperative BehaviorFemaleHealth Services AccessibilityHumansLogistic ModelsMaleMiddle AgedMotivational InterviewingMultivariate AnalysisNaltrexoneOpioid-Related DisordersBuprenorphine, Naloxone Drug CombinationNaltrexoneCommunity health centerFederally qualified health centerFQHCMATMedication-assisted treatmentPrimary careSubstance use disorder treatment predictors

Identifiers

PMID29866385
PMCPMC6336395
OpenAlexW2802721624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.